Clinical Trials · NCT01644500
A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 737
- Start date
- Jul 2012
- Locations
- 30 sites, 3 countries
- Primary endpoint
- Change From Baseline in HbA1c at 26 Weeks